Nuveen Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $15.7M | Buy |
491,107
+150,384
| +44% | +$4.8M | ﹤0.01% | 1320 |
|
|
2024
Q3 | $9.83M | Buy |
340,723
+60,722
| +22% | +$1.75M | ﹤0.01% | 1624 |
|
|
2024
Q2 | $10.7M | Buy |
280,001
+9,425
| +3% | +$362K | ﹤0.01% | 1536 |
|
|
2024
Q1 | $15.9M | Buy |
270,576
+56
| +0% | +$3.29K | ﹤0.01% | 1313 |
|
|
2023
Q4 | $16.2M | Sell |
270,520
-2,993
| -1% | -$179K | 0.01% | 1293 |
|
|
2023
Q3 | $10.4M | Buy |
273,513
+11,115
| +4% | +$423K | ﹤0.01% | 1461 |
|
|
2023
Q2 | $23.9M | Sell |
262,398
-87,156
| -25% | -$7.94M | 0.01% | 964 |
|
|
2023
Q1 | $23.1M | Sell |
349,554
-11,181
| -3% | -$738K | 0.01% | 950 |
|
|
2022
Q4 | $18.7M | Sell |
360,735
-49,666
| -12% | -$2.57M | 0.01% | 1089 |
|
|
2022
Q3 | $28M | Buy |
410,401
+34,201
| +9% | +$2.34M | 0.01% | 805 |
|
|
2022
Q2 | $17M | Buy |
376,200
+112,555
| +43% | +$5.09M | 0.01% | 1158 |
|
|
2022
Q1 | $13.7M | Buy |
263,645
+7,204
| +3% | +$375K | ﹤0.01% | 1436 |
|
|
2021
Q4 | $10.8M | Sell |
256,441
-9,803
| -4% | -$412K | ﹤0.01% | 1643 |
|
|
2021
Q3 | $9.11M | Sell |
266,244
-64,935
| -20% | -$2.22M | ﹤0.01% | 1843 |
|
|
2021
Q2 | $20.9M | Buy |
331,179
+67,218
| +25% | +$4.25M | 0.01% | 1330 |
|
|
2021
Q1 | $11.3M | Sell |
263,961
-4,455
| -2% | -$191K | ﹤0.01% | 1723 |
|
|
2020
Q4 | $15.4M | Sell |
268,416
-4,131
| -2% | -$236K | 0.01% | 1419 |
|
|
2020
Q3 | $8.22M | Buy |
272,547
+212
| +0.1% | +$6.4K | ﹤0.01% | 1633 |
|
|
2020
Q2 | $8.89M | Sell |
272,335
-88,470
| -25% | -$2.89M | ﹤0.01% | 1555 |
|
|
2020
Q1 | $9.67M | Buy |
360,805
+166,194
| +85% | +$4.45M | ﹤0.01% | 1311 |
|
|
2019
Q4 | $5.96M | Sell |
194,611
-20
| -0% | -$612 | ﹤0.01% | 1889 |
|
|
2019
Q3 | $4.69M | Buy |
194,631
+22,503
| +13% | +$542K | ﹤0.01% | 1991 |
|
|
2019
Q2 | $4.36M | Buy |
+172,128
| New | +$4.36M | ﹤0.01% | 2064 |
|